Vanessa Ding Email & Phone Number

Singapore, Sg

- Spearheaded the development and execution of the Helix Immersion Programme (HIP), creating a pipeline of highly skilled talent for Singapore’s biomedtech and deep tech sectors and supported biomedtech companies in Singapore.- Fostered partnerships with government agencies, academic institutions and industry leaders, aligning training programs with the needs of biomedtech companies to ensure participants’ readiness for industry roles.- Championed talent retention strategies, successfully integrating local graduates into Singapore’s biomedtech ecosystem and aligning with industry demands to expand the talent pool.- Tailored the HIP to equip participants with both technical skills and business acumen, facilitating smooth transitions from academia to industry and boosting long-term employability in biomedtech.- Established mentorship programs and performance tracking, ensuring continuous development and alignment of participants with industry trends while enhancing the program’s effectiveness.

Henderson, Nevada, Us

- Led Volition's business development efforts in the companion animal diagnostics market, driving the adoption of the Nucleosomics™ platform for non-invasive cancer detection in pets in Asia.- Cultivated strategic partnerships with veterinary clinics, animal hospitals, and diagnostic lab in Singapore to expand the availability of Volition's diagnostic tests for companion animals.- Conducted competitive market analysis within the veterinary diagnostics industry, identifying growth opportunities and positioning Volition’s products in Asia for the companion animal health market.- Represented Volition Veterinary Diagnostics at key veterinary conferences and industry forums, showcasing the benefits of Nucleosomics™ technology and driving awareness among veterinary professionals.

Singapore, Sg

BTI Strategic Positioning- Plan and develop BTI mid-long term strategic initiatives and research budget with BTI leadership through development and implementation of BTI playbook- Identified 4 key growth areas and lead the formation of growth area interdisciplinary teams- Involved in programme shaping and building for Advanced Bionanalytical Tools in biologics development- Manage and engage BTI strategic key accounts for long term partnerships plan (incl. MNC's and SME's) - Inter-Research Institute, A*STAR HQ, and inter-agencies stakeholders engagementConflict Management Office (CMO)- Manage COI for BTI staff- Manage personnel conflict for BTI

Singapore, Singapore, Sg

Educated researchers on startup methodologies and oversaw biotech startup portfolio management, fostering innovation and entrepreneurship.

Singapore, Sg

Singapore, Sg

Bioprocessing Technology Institute:- Antibody Discovery PlatformTeam Lead for breast cancer Indication (human breast cancer and canine mammary cancer)Team Lead for human corneal endothelial isolation project Academic Achievements:Total number of publications: 15 Total Patents Filed/Granted: 8 (1 ophthalmology; 4 human oncology; 3 canine oncology)Competitive Grant No. Competitive Grant Secured: 2Total grant quatum: > SGD$2 million1) Involved in technology transfer and generation of lead targets-Successfully transferred both cell lines and technology from the industries to perform lab scale experiments -Generated >10 lead target for various projects currently targets are in preclinical evaluation stage- Preparation of research collaboration agreement (RCA) - Lead in development of business plans for spin-off for companion animal project2) Workstream Lead, Research Competency and Development Framework (RCDF)- Led a team of six researchers across diverse domains at A*STAR, driving initiatives under the Research Development Task Force (RDTF).- Designed and implemented platforms to enhance the growth, socialisation, and career development of researchers, fostering a collaborative and innovative research environment.- Streamlined processes and enhanced engagement strategies, contributing to a more integrated and supportive research community within A*STAR.

Singapore, Sg

Bioprocessing Technology Institute :- Antibody Discovery Platform- Spearheaded the discovery of novel monoclonal antibodies against human cancers, contributing to the development of innovative therapeutics and diagnostics for breast and lung cancer.- Developed and patented monoclonal antibodies for human corneal endothelial cells, advancing alternative transplantation therapies and enhancing patient treatment options.

Singapore, Sg

Bioprocessing Technology Institute :- Antibody Discovery Platform- Conducted groundbreaking research in the Antibody Discovery Platform, leading to the identification of novel monoclonal antibodies targeting human cancers, enhancing therapeutic options.- Developed innovative monoclonal antibodies for human corneal endothelial cells, contributing to advancements in alternative transplantation therapies.- Collaborated with multidisciplinary teams to streamline research protocols, resulting in increased efficiency and output in antibody development.- Published findings in peer-reviewed journals, significantly advancing the field of cancer therapeutics and regenerative medicine.

Strategy Planning - Developed and implemented strategic plans to enhance drug development processes, aligning project goals with organisational objectives.

Singapore, Sg

Responsible for serum-free media development for human embryonics stem cells.

Responsible for managing and develop new accounts for industrial laundry detergent in Singapore.

Doctor Of Philosophy (Phd), Stem Cell Biology

Bachelor Of Engineering (B.Eng.), Chemical Engineering

Diploma In Chemical Engineering, Chemical Engineering